ULMarch 23, 2026 at 12:53 PM UTCHousehold & Personal Products

Unilever's Reported Foods Spin-Off with McCormick Adds Margin Pressure and Execution Risk to Already Complex Transformation

Read source article

What happened

Unilever is deep into a multi-year transformation, demerging its Ice Cream division and implementing a Growth Action Plan to sharpen focus on faster-growing Beauty & Wellbeing and Personal Care segments, as detailed in the DeepValue report. New reports suggest the company is also considering spinning off its Foods division to combine with US spice group McCormick, a move analyzed by UBS that would strip out 26% of group revenues and 29% of operating profit based on 2025 figures. UBS calculates this could boost the sales growth profile but dent underlying operating margins by 0.8-1 percentage point, introducing additional profitability headwinds. This potential Foods separation adds another layer of execution complexity to an already risky restructuring, threatening to undermine the €800m productivity savings meant to offset demerger dis-synergies from the Ice Cream spin-off. With Unilever trading at a rich 32x P/E and approximately 39% above its DCF-derived intrinsic value, any margin compression or delays in realizing transformation benefits could worsen investor skepticism and pressure the stock, which has shown virtually no progress over five years.

Implication

For investors, this development signals that Unilever's portfolio reshaping is more aggressive than previously anticipated, potentially accelerating growth but at the cost of near-term profitability and operational stability. The estimated margin dilution from the Foods move could hinder efforts to improve returns, a critical concern given the company's low-to-mid-single-digit growth and high valuation multiples. Execution risks escalate as managing multiple demergers concurrently increases the likelihood of disruptions, cost overruns, and distraction from core brand investments. In the short term, heightened uncertainty may keep the stock range-bound, echoing its flat five-year performance, until tangible benefits from the transformations materialize. Long-term, a successfully streamlined Unilever focused on premium segments might support higher valuations, but current prices offer minimal margin of safety, reinforcing a cautious or sell stance until execution proves more reliable.

Thesis delta

The prior investment thesis centered on the Ice Cream demerger and €800m productivity savings as primary transformation drivers with inherent execution risk. This news introduces a potential Foods spin-off that could enhance growth but at the expense of margins, adding complexity and increasing the burden on management to deliver flawless, simultaneous restructurings. Consequently, the thesis shifts toward greater skepticism, as the combined moves amplify the chances of value leakage, margin erosion, or delayed benefits, making the stock's premium valuation even less defensible.

Confidence

Moderate